title: Neurotrophic factors rescue basal forebrain cholinergic neurons and improve performance on a spatial learning test.
abstract: This study investigated whether animals sustaining experimental damage to the basal forebrain cholinergic system would benefit from treatment with exogenous neurotrophic factors. Specifically, we set out to determine whether neurotrophic factors would rescue damaged cholinergic neurons and improve behavioral performance on a spatial learning and memory task. Adult rats received bilateral injections of either saline (controls) or 192 IgG-saporin to damage basal forebrain cholinergic neurons (BFCNs). Two weeks later, animals received implants of an Alzet mini-pump connected to cannulae implanted bilaterally in the lateral ventricles. Animals received infusions of nerve growth factor (NGF), neurotrophin 3 (NT3), a combination of NGF and NT3, or a saline control over a 4-week period. Compared to saline-treated controls, animals sustaining saporin-induced damage to BFCNs took significantly more trials to learn a delayed match to position task and also performed more poorly on subsequent tests, with increasing delays between test runs. In contrast, animals infused with neurotrophins after saporin treatment performed significantly better than animals receiving saline infusions; no differences were detected for performance scores among animals infused with NGF, NT3, or a combination of NGF and NT3. Studies of ChAT immunnocytochemical labeling of BFCNs revealed a reduction in the numbers of ChAT-positive neurons in septum, nucleus of diagonal band, and nucleus basalis in animals treated with saporin followed by saline infusions, whereas animals treated with infusions of NGF, NT3 or a combination of NGF and NT3 showed only modest reductions in ChAT-positive neurons. Together, these data support the notion that administration of neurotrophic factors can rescue basal forebrain cholinergic neurons and improve learning and memory performance in rats.
authors.affiliation: Department of Anatomy and Neurobiology, School of Medicine, University of California, Irvine, CA, USA; Physical Medicine and Rehabilitation, School of Medicine, University of California, Irvine, CA, USA; Department of Neuroscience, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA. Electronic address: leey2@ccf.org.
authors.forename: Yu-Shang
authors.initials: YS
authors.lastname: Lee
authors.forename: Andalib
authors.initials: A
authors.lastname: Danandeh
authors.forename: Janie
authors.initials: J
authors.lastname: Baratta
authors.forename: Ching-Yi
authors.initials: CY
authors.lastname: Lin
authors.forename: Jen
authors.initials: J
authors.lastname: Yu
authors.forename: Richard T
authors.initials: RT
authors.lastname: Robertson
mesh_terms: D000818:Animals; D059329:Cholinergic Neurons / Q000187:drug effects / Q000502:physiology*; D015918:Infusion Pumps, Implantable; D057967:Infusions, Intraventricular; D007858:Learning / Q000187:drug effects / Q000502:physiology*; D009414:Nerve Growth Factors / Q000008:administration & dosage / Q000502:physiology*; D016548:Prosencephalon / Q000187:drug effects / Q000502:physiology*; D011597:Psychomotor Performance / Q000502:physiology*; D011897:Random Allocation; D051381:Rats; D017207:Rats, Sprague-Dawley; D013037:Spatial Behavior / Q000187:drug effects / Q000502:physiology*
chemical_list: D009414:Nerve Growth Factors
keywords: Basal forebrain; ChAT; Choline acetyltransferase; Cholinergic; NGF; NT3; Neuronal plasticity; Neurotrophins; Target selection
references.citation: Neuroscience. 1998 May;84(1):101-14
references.pmid: 9522366
references.citation: Neurosci Biobehav Rev. 2003 Sep;27(4):365-76
references.pmid: 12946689
references.citation: J Comp Neurol. 1996 Sep 23;373(3):451-65
references.pmid: 8889938
references.citation: Nat Med. 2005 May;11(5):551-5
references.pmid: 15852017
references.citation: Brain Res. 1995 Jun 12;683(1):129-39
references.pmid: 7552337
references.citation: Neuroscience. 1989;28(2):291-336
references.pmid: 2646551
references.citation: Crit Rev Neurobiol. 2005;17(3-4):161-217
references.pmid: 17341198
references.citation: Can J Psychol. 1951 Sep;5(3):122-8
references.pmid: 14870071
references.citation: J Comp Neurol. 1999 Apr 5;406(2):156-70
references.pmid: 10096603
references.citation: Behav Brain Res. 2011 Aug 10;221(2):430-42
references.pmid: 21108972
references.citation: Brain Res Bull. 2005 Jan 15;64(5):381-94
references.pmid: 15607826
references.citation: Brain Res Dev Brain Res. 2001 Dec 14;132(1):15-21
references.pmid: 11744103
references.citation: Neurosci Lett. 1987 Mar 20;75(1):6-10
references.pmid: 3574769
references.citation: J Neurosci. 1993 Dec;13(12):5263-76
references.pmid: 8254373
references.citation: Behav Brain Res. 2011 Aug 10;221(2):379-88
references.pmid: 21272598
references.citation: Neuroscience. 2006 Dec 1;143(2):523-39
references.pmid: 17049175
references.citation: Neurobiol Aging. 1992 May-Jun;13(3):393-400
references.pmid: 1625768
references.citation: Trends Pharmacol Sci. 1989 Apr;10(4):145-9
references.pmid: 2665246
references.citation: J Neurosci. 2006 Jul 19;26(29):7756-66
references.pmid: 16855103
references.citation: J Neurosci. 1995 Apr;15(4):2888-905
references.pmid: 7536822
references.citation: Brain Res Bull. 2013 May;94:9-16
references.pmid: 23357177
references.citation: Neuroscience. 1983 Dec;10(4):1185-201
references.pmid: 6320048
references.citation: Brain Res. 1990 Feb 5;508(2):241-8
references.pmid: 2306615
references.citation: Neurobiol Aging. 2012 May;33(5):867-77
references.pmid: 20961662
references.citation: Behav Brain Res. 2011 Aug 10;221(2):389-411
references.pmid: 21108971
references.citation: Neuroscience. 2003;119(4):1055-69
references.pmid: 12831864
references.citation: Neuron. 1990 Sep;5(3):297-306
references.pmid: 2169269
references.citation: Science. 1982 Jul 30;217(4558):408-14
references.pmid: 7046051
references.citation: Neuroscience. 2008 Jul 17;154(4):1607-18
references.pmid: 18515016
references.citation: Exp Neurol. 1988 Aug;101(2):303-12
references.pmid: 3396647
references.citation: Neurosci Biobehav Rev. 2011 May;35(6):1397-409
references.pmid: 21392524
references.citation: Exp Neurol. 2004 Sep;189(1):162-72
references.pmid: 15296846
references.citation: Cereb Cortex. 1998 Mar;8(2):142-55
references.pmid: 9542893
references.citation: Prog Neurobiol. 2002 Oct;68(3):209-45
references.pmid: 12450488
references.citation: Prog Neurobiol. 1999 Feb;57(4):451-84
references.pmid: 10080385
references.citation: Brain Res. 2002 Jul 5;943(1):132-41
references.pmid: 12088847
references.citation: Annu Rev Neurosci. 2001;24:677-736
references.pmid: 11520916
references.citation: Toxicol In Vitro. 2013 Feb;27(1):220-31
references.pmid: 23085102
references.citation: Mol Cell Neurosci. 1994 Feb;5(1):46-62
references.pmid: 8087414
references.citation: Nature. 1966 May 7;210(5036):657-8
references.pmid: 5964587
references.citation: Behav Brain Res. 2011 Aug 10;221(2):356-66
references.pmid: 21129407